|
Kolltan |
New Haven, CT |
|
Founder |
12/2007 - Present |
|
Established the framework for founding the company and supervising research and drug discovery. Founder, Member of the Board and Chairman of Scientific Advisory Board. Founded the company and raised nearly $40 millions for its operations.
|
|
|
Yale University School of Medicine |
New Haven, CT |
|
Professor and Chairman of Pharmacology Department |
11/2000 - Present |
|
Supervise a research group, train graduate students and postdoctoral fellows. Elucidation of mechanism of RTK activation.
|
|
|
Plexxikon |
Berkeley, CA |
|
Founder and Chairman of the Board |
7/2000 - Present |
|
Established the framework for founding the company and supervising research and drug discovery. Founder, Chairman of the board and member of scientific advisory board. Discovery of a selective Raf inhibitor in clinical trial for melanoma.
|
|